Changes in the cervical microbiota of cervical cancer patients after primary radio-chemotherapy
Open Access
- 5 May 2020
- journal article
- research article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 30 (9), 1326-1330
- https://doi.org/10.1136/ijgc-2019-000801
Abstract
Objective Several recent studies have identified a potential interaction between the vaginal microbiota and gynecological cancers, but little is known about the cervical microbiota and its changes during cancer treatment. Therefore, the aim of the study was to evaluate the quantitative and qualitative changes of cervical microbiota in patients undergoing concurrent chemotherapy and radiation treatment for locally advanced cervical cancer. Methods Cervical cytobrush samples of 15 cervical patients undergoing chemoradiation treatment were collected 1 day before starting external beam radiation therapy and on the day of the last fraction of brachytherapy. After DNA extraction, 16S rRNA amplicon sequencing of the V3–V4 region was performed on the MiSeq platform, followed by data processing and statistical analyses concerning the alpha and beta diversity of 16 samples (7 samples were excluded because of incomplete sample sets). Results The amount of amplicon yield after polymerase chain reaction analysis in post-radiation samples was significantly lower compared with the baseline samples (pre 31.49±24.07 ng/µl; post 1.33±1.94 ng/µl; p=0.007). A comparison of pre-treatment and post-treatment samples did not show significant differences regarding beta diversity (weighted UniFrac). There was no significant difference in alpha diversity, which is used to characterize species diversity within a particular community and takes into account both number and abundance (Shannon Diversity Index pre-treatment samples: 2.167±0.7504 (95% CI 1.54 to 2.79); post-treatment samples: 1.97±0.43 (95% CI 1.61 to 2.33); p=0.38). Interindividual differences in patients could partly explain some variation of the samples (permutational multivariate analysis of variance). Conclusion There was a strong reduction in cervical bacterial loads after chemoradiation. Neither alpha nor beta diversity varied significantly when baseline samples were compared with post-treatment samples.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG Grant HE-6810/3-1, J. Herter, MD.)
This publication has 28 references indexed in Scilit:
- Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot StudyPLOS ONE, 2015
- Interplay Between the Temporal Dynamics of the Vaginal Microbiota and Human Papillomavirus DetectionThe Journal of Infectious Diseases, 2014
- Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive PyrosequencingPLOS ONE, 2013
- phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census DataPLOS ONE, 2013
- The SILVA ribosomal RNA gene database project: improved data processing and web-based toolsNucleic Acids Research, 2012
- Bacterial Vaginosis and the Natural History of Human PapillomavirusInfectious Diseases in Obstetrics and Gynecology, 2011
- Screening for Cytomegalovirus during PregnancyInfectious Diseases in Obstetrics and Gynecology, 2011
- NWChem: A comprehensive and scalable open-source solution for large scale molecular simulationsComputer Physics Communications, 2010
- Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patientsRadiation Oncology, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010